Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Express Scripts
Medtronic
Harvard Business School
Baxter

Last Updated: August 19, 2022

Investigational Drug Information for Givinostat


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Givinostat?

Givinostat is an investigational drug.

There have been 14 clinical trials for Givinostat. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2017.

The most common disease conditions in clinical trials are Muscular Dystrophies, Muscular Dystrophy, Duchenne, and Arthritis, Juvenile. The leading clinical trial sponsors are Italfarmaco, Parexel, and inVentiv Health Clinical.

There are two hundred and sixty-five US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Givinostat
TitleSponsorPhase
Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp ActivityItalfarmacoPhase 1
Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC IntervalItalfarmacoPhase 1
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular DystrophyItalfarmacoPhase 2

See all Givinostat clinical trials

Clinical Trial Summary for Givinostat

Top disease conditions for Givinostat
Top clinical trial sponsors for Givinostat

See all Givinostat clinical trials

US Patents for Givinostat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Givinostat See Plans and Pricing Histone deacetylase inhibitors and methods for use thereof REACTION BIOLOGY CORP. (Malvern, PA) See Plans and Pricing
Givinostat See Plans and Pricing Anti-CS1 antibodies and antibody drug conjugates AbbVie Biotherapeutics Inc. (Redwood City, CA) See Plans and Pricing
Givinostat See Plans and Pricing Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL) See Plans and Pricing
Givinostat See Plans and Pricing Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III Frequency Therapeutics, Inc. (Woburn, MA) See Plans and Pricing
Givinostat See Plans and Pricing Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Givinostat

Drugname Country Document Number Estimated Expiration Related US Patent
Givinostat World Intellectual Property Organization (WIPO) WO2017030892 2035-08-14 See Plans and Pricing
Givinostat Australia AU2015339012 2034-10-31 See Plans and Pricing
Givinostat Brazil BR112017008945 2034-10-31 See Plans and Pricing
Givinostat Canada CA2966005 2034-10-31 See Plans and Pricing
Givinostat European Patent Office EP3212668 2034-10-31 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Express Scripts
Medtronic
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.